Market Place
Sourcing Support
Quantum Cyber Aligns Strategy With National Cyber Security
17 Mar 2026 //
GLOBENEWSWIRE
Quantum Cyber Changes Nasdaq Ticker to QUCY
13 Mar 2026 //
GLOBENEWSWIRE
Mainz Biomed Names Robert Liscouski Chairman Of Board
11 Mar 2026 //
GLOBENEWSWIRE
Mainz Biomed to Present mRNA Biomarker Data at DDW
24 Feb 2026 //
GLOBENEWSWIRE
Mainz Biomed Reveals $6M Private Placement And Strategic Update
17 Feb 2026 //
GLOBENEWSWIRE
Mainz Biomed`s Pancreatic Cancer Study Heads to AACR 2026
14 Jan 2026 //
GLOBENEWSWIRE
Mainz Biomed Provides Review Of 2025 Highlights
05 Jan 2026 //
GLOBENEWSWIRE
Doctorbox Adds Mainz Biomed`s Coloalert(R) To Its Portfolio
02 Dec 2025 //
GLOBENEWSWIRE
Mainz Biomed, Oncovanguard8 Partner To Introduce Coloalert
18 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed Unveils Cancer Detection Innovations at MEDICA 2025
12 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed at 38th GARPS Gastroenterological Meeting
10 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed To Attend 2025 Maxim Growth Summit
15 Oct 2025 //
GLOBENEWSWIRE
Mainz Bio Reports Feasibility Results In Pancreatic Cancer Study
08 Oct 2025 //
GLOBENEWSWIRE
Mainz Biomed to Present CRC Screening Future at WEO Meeting
30 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Launches Coloalert® In Switzerland
23 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Registers ColoAlert in the UK
02 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Gets Swiss Approval for ColoAlert® Marketing
13 Aug 2025 //
GLOBENEWSWIRE
Mainz Biomed Prices $3.0 M Follow-On Offering of Shares
04 Aug 2025 //
GLOBENEWSWIRE
FDA Fast-Tracks NextGen Colorectal, Pancreatic Cancer Screenings
15 Jul 2025 //
GLOBENEWSWIRE
Mainz Biomed secures funding for pancreatic cancer test
25 Jun 2025 //
GLOBENEWSWIRE
Mainz Biomed Starts Study on Biomarker Panel in Pancreatic Cancer
10 Jun 2025 //
GLOBENEWSWIRE
Mainz Biomed Prices $4.0M Follow-On Offering of Shares
19 May 2025 //
GLOBENEWSWIRE
Mainz Biomed Announces Interim Results for eAArly Detect 2 Study
16 May 2025 //
GLOBENEWSWIRE
Mainz Biomed partners with EDX Medical Group
29 Apr 2025 //
GLOBENEWSWIRE
Mainz Biomed`s Q1 2025 Update and FDA Premarket Approval
28 Apr 2025 //
GLOBENEWSWIRE
Mainz Biomed Reports 2024 Financial Results and Corporate Update
01 Apr 2025 //
GLOBENEWSWIRE
Mainz Biomed Enrolls First Patient in eAArly DETECT 2 Study
27 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed & Liquid Discover mRNA Biomarkers for Pancreatic Cancer
13 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed Urges Shift From Screening To Prevention In CRC
03 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed Expands into Switzerland with labor team w
20 Feb 2025 //
GLOBENEWSWIRE
Mainz Biomed, Ganzimmun Launch Enhanced ColoAlert Cancer Screening
11 Feb 2025 //
GLOBENEWSWIRE
Mainz Biomed Regains Compliance With Nasdaq Listing Requirements
27 Jan 2025 //
PHARMAWEB
Mainz Biomed Regains Compliance With Nasdaq Listing Rules
27 Jan 2025 //
GLOBENEWSWIRE
Mainz Biomed Initiates Study On Next-Gen Test For Advanced Adenomas
21 Jan 2025 //
PHARMAWEB
Mainz Begins Study On Adenoma Test Performance In Large Population
21 Jan 2025 //
GLOBENEWSWIRE
Mainz Biomed Partners with Quest for Colorectal Cancer Test Trials
19 Dec 2024 //
GLOBENEWSWIRE
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
16 Dec 2024 //
GLOBENEWSWIRE
Mainz Biomed Prices $8.0M Follow-On Offering Under Nasdaq Rules
12 Dec 2024 //
GLOBENEWSWIRE
Mainz Biomed Announces Stock Split
29 Nov 2024 //
GLOBENEWSWIRE
Mainz & Thermo Fisher Collaborate on Colorectal Cancer Screening
12 Nov 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Mid-Year 2024 Financial Results And Update
21 Oct 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Increased Demand For Enhanced ColoAlert
08 Oct 2024 //
GLOBENEWSWIRE
Mainz Biomed CEO Eyes Growth and FDA Trials in 2025
01 Oct 2024 //
GLOBENEWSWIRE
Mainz Biomed Appoints Petra Smeltzer Starke As Ambassador
18 Sep 2024 //
GLOBENEWSWIRE
Mainz Biomed Partners With Liquid Biosciences For PancAlert
04 Sep 2024 //
GLOBENEWSWIRE
Mainz Biomed Launches Enhanced ColoAlert For Better Screening Efficiency
25 Jul 2024 //
GLOBENEWSWIRE
Mainz Biomed Announces Submission For FDA Breakthrough
09 Jul 2024 //
GLOBENEWSWIRE
Mainz Biomed Provides Half Year 2024 Corporate Update
02 Jul 2024 //
GLOBENEWSWIRE
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
03 Jun 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Results of 2024 Annual General Meeting
31 May 2024 //
GLOBENEWSWIRE
Mainz Biomed: Largest Colorectal Cancer Screening Data At ASCO 2024
28 May 2024 //
GLOBENEWSWIRE
Mainz Biomed Awarded Poster At DDW Ahead Of FDA Trial
20 May 2024 //
GLOBENEWSWIRE
Mainz Biomed to present results from colorectal cancer screening at DDW 2024
09 May 2024 //
PHARMABIZ
Mainz Biomed To Present Colorectal Cancer Screening Study At DDW 2024
07 May 2024 //
GLOBENEWSWIRE
Mainz Reports Positive CRC Biomarker AI Algorithm Results
25 Apr 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Full Year 2023 Financial Results
09 Apr 2024 //
GLOBENEWSWIRE
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in CCT
19 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - New Laboratory
18 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer
18 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed Presents ColoAlert® at UDH Congress 2024
12 Mar 2024 //
GLOBENEWSWIRE
